ATE510542T1 - Noribogain zur behandlung von schmerzen und drogenabhängigkeit - Google Patents

Noribogain zur behandlung von schmerzen und drogenabhängigkeit

Info

Publication number: ATE510542T1
Authority: AT; Austria
Prior art keywords: noribogain; drug dependence; treat pain; noribogaine; pain
Prior art date: 1997-09-04

Application number

AT03075683T

Other languages

English (en)

Inventor

Deborah C Mash

Original Assignee

Novoneuron Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-04

Filing date

1998-09-03

Publication date

2011-06-15

1998-09-03 Application filed by Novoneuron Inc filed Critical Novoneuron Inc

2011-06-15 Application granted granted Critical

2011-06-15 Publication of ATE510542T1 publication Critical patent/ATE510542T1/de

Links

206010013663 drug dependence Diseases 0.000 title 1
208000011117 substance-related disease Diseases 0.000 title 1
RAUCDOKTMDOIPF-UHFFFAOYSA-N hydroxyibogamine Natural products CCC1CC(C2)CC3C1N2CCC1=C3NC2=CC=C(O)C=C12 RAUCDOKTMDOIPF-UHFFFAOYSA-N 0.000 abstract 3
RAUCDOKTMDOIPF-RYRUWHOVSA-N noribogaine Chemical compound N1([C@@H]2[C@H]3C[C@H](C1)C[C@@H]2CC)CCC1=C3NC2=CC=C(O)C=C12 RAUCDOKTMDOIPF-RYRUWHOVSA-N 0.000 abstract 3
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 abstract 1
229960004127 naloxone Drugs 0.000 abstract 1
239000003401 opiate antagonist Substances 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Addiction (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)

AT03075683T 1997-09-04 1998-09-03 Noribogain zur behandlung von schmerzen und drogenabhängigkeit ATE510542T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5792197P	1997-09-04	1997-09-04

Publications (1)

Publication Number	Publication Date
ATE510542T1 true ATE510542T1 (de)	2011-06-15

Family

ID=22013572

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT98944698T ATE265213T1 (de)	1997-09-04	1998-09-03	Noribogain zur behandlung von schmerzen und drogenabhängigkeit
AT03075683T ATE510542T1 (de)	1997-09-04	1998-09-03	Noribogain zur behandlung von schmerzen und drogenabhängigkeit

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT98944698T ATE265213T1 (de)	1997-09-04	1998-09-03	Noribogain zur behandlung von schmerzen und drogenabhängigkeit

Country Status (9)

Country	Link
US (6)	US7754710B2 (de)
EP (4)	EP2246058A1 (de)
AT (2)	ATE265213T1 (de)
AU (1)	AU754088B2 (de)
CA (1)	CA2302754C (de)
DE (1)	DE69823520T2 (de)
ES (3)	ES2224430T3 (de)
IL (2)	IL134796A0 (de)
WO (1)	WO1999011250A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001052851A1 (en) *	2000-01-22	2001-07-26	Albert Shulman	Methods for the treatment of substance abuse
JP4522652B2 (ja)	2001-05-11	2010-08-11	エンドーファーマシューティカルズ，インコーポレイティド	乱用防止制御放出オピオイド投薬形態
CA2778114A1 (en) *	2001-05-11	2002-11-21	Endo Pharmaceuticals, Inc.	Abuse-resistant opioid dosage form
LT2425824T (lt)	2002-04-05	2017-07-25	Euro-Celtique S.A.	Farmacinis preparatas, turintis oksikodono ir naloksono
EP1702558A1 (de)	2005-02-28	2006-09-20	Euro-Celtique S.A.	Verfahren und Vorrichtung zur Darmtätigkeitserfassung
HUE042105T2 (hu)	2009-03-10	2019-06-28	Euro Celtique Sa	Oxikodont és naloxont tartalmazó azonnali hatóanyagleadású orális gyógyászati készítmények
US8765737B1 (en)	2010-05-11	2014-07-01	Demerx, Inc.	Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en)	2010-05-11	2016-07-19	Demerx, Inc.	Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) *	2010-05-11	2013-01-29	Demerx, Inc.	Substituted noribogaine
US8741891B1 (en)	2010-06-22	2014-06-03	Demerx, Inc.	N-substituted noribogaine prodrugs
US9586954B2 (en)	2010-06-22	2017-03-07	Demerx, Inc.	N-substituted noribogaine prodrugs
US8637648B1 (en)	2010-06-22	2014-01-28	Demerx, Inc.	Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en)	2010-06-22	2014-08-12	Demerx, Inc.	Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
MX2013000733A (es) *	2010-07-23	2013-05-30	Demerx Inc	Composiciones de noribogaina.
EP2481740B1 (de) *	2011-01-26	2015-11-04	DemeRx, Inc.	Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
US8742096B2 (en)	2011-03-28	2014-06-03	Demerx, Inc.	Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en)	2011-08-26	2017-04-11	Demerx, Inc.	Synthetic noribogaine
PE20142353A1 (es) *	2011-09-15	2015-01-10	Demerx Inc	Ansolvatos de sal de noribogaina
CA3122767C (en) *	2011-12-08	2023-03-28	Demerx, Inc.	Stereoselective total synthesis of noribogaine
EP2788356A4 (de) *	2011-12-09	2015-10-21	Demerx Inc	Sulfatester aus noribogain
CA2855994A1 (en)	2011-12-09	2013-06-13	Demerx, Inc.	Phosphate esters of noribogaine
AU2013212139A1 (en)	2012-01-25	2014-06-26	Demerx, Inc.	Synthetic voacangine
US9150584B2 (en)	2012-01-25	2015-10-06	Demerx, Inc.	Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9045481B2 (en)	2012-12-20	2015-06-02	Demerx, Inc.	Substituted noribogaine
US8940728B2 (en)	2012-12-20	2015-01-27	Demerx, Inc.	Substituted noribogaine
WO2014098877A1 (en)	2012-12-20	2014-06-26	Demerx, Inc.	Substituted noribogaine
CA3256416A1 (en) *	2013-03-15	2025-06-21	Demerx, Inc.	METHOD FOR THE TREATMENT OF ADDICTION IN PATIENTS UNDER METHADONE WITH NORIBOGAINE
EP3024461B1 (de)	2013-07-23	2020-05-13	Euro-Celtique S.A.	Kombination aus oxycodon und naloxon für die verwendung bei der behandlung von schmerzen bei patienten mit schmerzen und einer krankheit, die zur intestinaldysbiose und/oder erhöhung der gefahr bakterieller translokation führt
EP3082816B1 (de)	2013-12-20	2019-03-20	Indivior UK Limited	Intranasale naloxonzusammensetzungen und verfahren zur herstellung und verwendung davon
AU2015219172A1 (en) *	2014-02-18	2016-09-29	Demerx, Inc.	Therapeutic methods employing noribogaine and related compounds
US9345711B2 (en) *	2014-02-18	2016-05-24	Demerx, Inc.	Methods for acute and long-term treatment of drug addiction
US9561232B2 (en)	2014-02-18	2017-02-07	Demerx, Inc.	Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
KR20160120781A (ko) *	2014-02-18	2016-10-18	데메알엑스, 인크.	약물 중독의 급성 및 장기간 치료 방법
US20150246055A1 (en) *	2014-03-03	2015-09-03	Demerx, Inc.	Methods for acute and long-term treatment of opioid and opioid-like drug addiction
US9591978B2 (en)	2014-03-13	2017-03-14	Demerx, Inc.	Methods and compositions for pre-screening patients for treatment with noribogaine
US20150258111A1 (en) *	2014-03-13	2015-09-17	Demerx, Inc.	Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereof
WO2015142346A1 (en) *	2014-03-20	2015-09-24	Demerx, Inc.	Methods and compositions for preparing and purifying noribogaine
US9550789B2 (en)	2014-06-18	2017-01-24	Demerx, Inc.	Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en)	2014-07-14	2017-01-24	Demerx, Inc.	Methods and compositions for treating migraines using noribogaine
US9592239B2 (en)	2014-09-12	2017-03-14	Demerx, Inc.	Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
PT3223906T (pt) *	2014-11-26	2021-05-05	Demerx Inc	Métodos e composições para potencializar a ação de analgésicos de opioides usando alcaloides de iboga
WO2016183244A1 (en) *	2015-05-11	2016-11-17	Demerx, Inc.	Methods for treatment of opioid dependency and withdrawal using noribogaine
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en)	2017-10-09	2025-11-04	Compass Pathfinder Limited	Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US12377112B2 (en)	2019-04-17	2025-08-05	Compass Pathfinder Limited	Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
WO2025259800A2 (en) *	2024-06-11	2025-12-18	Demerx, Inc.	Method of treating chemical dependency

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB841697A (en) *	1956-03-22	1960-07-20	Ciba Ltd	Analgesic compositions
GB924042A (en)	1959-03-05	1963-04-18	Geigy Ag J R	Process for the decarboxylation of alkyl esters of unsaturated, nitrogen-containing carboxylic acids
US3639408A (en)	1967-06-03	1972-02-01	Shionogi & Co	Process for the preparation of isoquinuclidine derivatives
US3516989A (en)	1967-10-02	1970-06-23	American Home Prod	Intermediates for total synthesis of iboga alkaloids and means of preparation
FR7131M (de)	1968-01-31	1969-07-21
US3574220A (en)	1969-08-14	1971-04-06	American Home Prod	1,7-methano-1h-1-benzazepin-5(4h)-ones
US3557126A (en)	1969-08-14	1971-01-19	American Home Prod	Derivatives of iboga alkaloids
CA982478A (en)	1971-04-12	1976-01-27	Jerome Berk	Orally administered drug composition for therapy in the treatment of narcotic drug addiction
US4375414A (en)	1971-05-20	1983-03-01	Meir Strahilevitz	Immunological methods for removing species from the blood circulatory system and devices therefor
US3715361A (en) *	1971-10-08	1973-02-06	American Cyanamid Co	Acyl derivatives of 10-methoxyibogamine
US3875011A (en)	1972-11-06	1975-04-01	Syva Co	Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4272541A (en)	1978-06-02	1981-06-09	Miles Laboratories, Inc.	7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
US4464378A (en)	1981-04-28	1984-08-07	University Of Kentucky Research Foundation	Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
CA1188989A (en)	1981-05-21	1985-06-18	Richard R. Scherschlicht	Nonapeptide for the treatment of drug withdrawal symptoms
US4604365A (en)	1981-06-02	1986-08-05	Electro-Nucleonics, Inc.	Immunoprecipitation assay
US4462941A (en)	1982-06-10	1984-07-31	The Regents Of The University Of California	Dynorphin amide analogs
JPS59208119A (ja) *	1983-05-13	1984-11-26	Sankei Giken Kogyo Kk	触媒コンバ−タ
US4499096A (en)	1983-11-18	1985-02-12	Lotsof Howard S	Rapid method for interrupting the narcotic addiction syndrome
US5266574A (en) *	1984-04-09	1993-11-30	Ian S. Zagon	Growth regulation and related applications of opioid antagonists
US4626539A (en)	1984-08-10	1986-12-02	E. I. Dupont De Nemours And Company	Trandermal delivery of opioids
US4573995A (en) *	1984-10-09	1986-03-04	Alza Corporation	Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
GB8430346D0 (en)	1984-11-30	1985-01-09	Reckitt & Colmann Prod Ltd	Analgesic compositions
DE3587616D1 (de) *	1984-12-22	1993-11-11	Sanol Arznei Schwarz Gmbh	Wirkstoffpflaster.
US4806341A (en)	1985-02-25	1989-02-21	Rutgers, The State University Of New Jersey	Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US4587243A (en)	1985-07-15	1986-05-06	Lotsof Howard S	Rapid method for interrupting the cocaine and amphetamine abuse syndrome
US5316759A (en)	1986-03-17	1994-05-31	Robert J. Schaap	Agonist-antagonist combination to reduce the use of nicotine and other drugs
GB8625941D0 (en) *	1986-10-30	1986-12-03	Sandoz Ltd	Substituted alpha-amino acids
US4857523A (en)	1988-07-18	1989-08-15	Nda International, Inc.	Rapid method for attenuating the alcohol dependency syndrome
US5629307A (en)	1989-10-20	1997-05-13	Olney; John W.	Use of ibogaine in reducing excitotoxic brain damage
US5075341A (en)	1989-12-01	1991-12-24	The Mclean Hospital Corporation	Treatment for cocaine abuse
DE4010079A1 (de)	1990-03-29	1991-10-02	Lohmann Therapie Syst Lts	Pharmazeutische formulierung zur behandlung des alkoholismus
US5026697A (en)	1990-05-30	1991-06-25	Nda International, Inc.	Rapid method for interrupting or attenuating the nicotine/tobacco dependency syndrome
US5152994A (en)	1990-05-31	1992-10-06	Lotsof Howard S	Rapid method for interrupting or attenuating poly-drug dependency syndromes
US5283247A (en)	1991-02-06	1994-02-01	Research Corporation Technologies, Inc.	Anticonvulsant substituted quinazolones
US5149538A (en)	1991-06-14	1992-09-22	Warner-Lambert Company	Misuse-resistive transdermal opioid dosage form
US5290784A (en)	1991-07-18	1994-03-01	Yueqian Qu	Aconitane derivatives used as a medication to treat addiction
ES2123642T3 (es)	1992-04-10	1999-01-16	Merrell Pharma Inc	Metodo para el tratamiento del cancer por terapia conjunta con derivados de 2'-halometilideno y un agente antineoplasico especifico de fase s o fase m.
HUT70160A (en)	1992-06-12	1995-09-28	Des Tyr Dynorphin Partnership	Process for producing des-tyr dynorphin analogues
US5256669A (en) *	1992-08-07	1993-10-26	Aminotek Sciences, Inc.	Methods and compositions for treating acute or chronic pain and drug addiction
EP0668764A1 (de)	1992-09-21	1995-08-30	QIN, Bo-yi	Verfahren zur identifikation und verwendung von opioidanalgetika mit niedrigem bzw. ohne abhängigkeitspotential
US5580876A (en)	1992-09-21	1996-12-03	Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University	Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
CN1042895C (zh)	1992-09-23	1999-04-14	曲曰谦	治疗吸毒者戒断综合症及脱瘾的药物组合物
WO1994014490A1 (de)	1992-12-23	1994-07-07	Bernhard Hugemann	Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
US5865444A (en) *	1994-03-21	1999-02-02	Deere & Company	Body leveling suspension including a pivoting arrangement
JP2819236B2 (ja)	1994-05-06	1998-10-30	日東電工株式会社	経皮吸収製剤
US5552406A (en)	1994-06-17	1996-09-03	The Mclean Hospital Corporation	Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists
FR2721945B1 (fr)	1994-07-04	1996-10-18	David Fabrice	Accroissement genique, un procede d'amplicication genique isotherme et ses applications
AU4613296A (en)	1994-07-25	1996-04-19	Nda International, Inc.	A method of treating chemical dependency in mammals and a composition therefor
US5591738A (en) *	1994-10-14	1997-01-07	Nda International, Inc.	Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof
US5760044A (en)	1996-05-16	1998-06-02	Archer; Sydney	Method for treating cocaine and amphetamine dependency
US6451806B2 (en) *	1999-09-29	2002-09-17	Adolor Corporation	Methods and compositions involving opioids and antagonists thereof
US6864271B2 (en) *	2002-11-12	2005-03-08	The Foundation For The Lsu Health Sciences Center	Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives
AU2004200486B2 (en)	2003-02-12	2007-06-07	Samsung Electronics Co., Ltd.	Complex wireless service apparatus using wired and wireless communication systems and method thereof
US6806291B1 (en) *	2003-10-09	2004-10-19	The Foundation For The Lsu Health Sciences Center	Analgesic compounds, their synthesis and pharmaceutical compositions containing them

1998
- 1998-09-03 EP EP10170898A patent/EP2246058A1/de not_active Withdrawn
- 1998-09-03 CA CA2302754A patent/CA2302754C/en not_active Expired - Fee Related
- 1998-09-03 IL IL13479698A patent/IL134796A0/xx active IP Right Grant
- 1998-09-03 WO PCT/US1998/018284 patent/WO1999011250A2/en not_active Ceased
- 1998-09-03 AT AT98944698T patent/ATE265213T1/de active
- 1998-09-03 ES ES98944698T patent/ES2224430T3/es not_active Expired - Lifetime
- 1998-09-03 ES ES03075683T patent/ES2395268T3/es not_active Expired - Lifetime
- 1998-09-03 EP EP98944698A patent/EP1009407B1/de not_active Expired - Lifetime
- 1998-09-03 AT AT03075683T patent/ATE510542T1/de active
- 1998-09-03 AU AU92174/98A patent/AU754088B2/en not_active Ceased
- 1998-09-03 ES ES10180121T patent/ES2435722T3/es not_active Expired - Lifetime
- 1998-09-03 EP EP03075683A patent/EP1327447B1/de not_active Expired - Lifetime
- 1998-09-03 DE DE69823520T patent/DE69823520T2/de not_active Expired - Lifetime
- 1998-09-03 EP EP10180121.5A patent/EP2338494B1/de not_active Expired - Lifetime
2000
- 2000-02-29 IL IL134796A patent/IL134796A/en not_active IP Right Cessation
2007
- 2007-04-06 US US11/784,343 patent/US7754710B2/en not_active Expired - Fee Related
2010
- 2010-06-08 US US12/796,241 patent/US20100311722A1/en not_active Abandoned
- 2010-06-08 US US12/796,247 patent/US20100311723A1/en not_active Abandoned
- 2010-06-08 US US12/796,249 patent/US8178524B2/en not_active Expired - Fee Related
- 2010-06-15 US US12/815,908 patent/US20100311725A1/en not_active Abandoned
2011
- 2011-12-08 US US13/315,127 patent/US20120083485A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20100311723A1 (en)	2010-12-09
CA2302754A1 (en)	1999-03-11
US20100311722A1 (en)	2010-12-09
EP2246058A1 (de)	2010-11-03
IL134796A (en)	2008-11-26
WO1999011250A3 (en)	1999-08-05
DE69823520T2 (de)	2005-05-12
US8178524B2 (en)	2012-05-15
EP2338494B1 (de)	2013-07-10
AU754088B2 (en)	2002-11-07
EP2338494A1 (de)	2011-06-29
ES2435722T3 (es)	2013-12-23
ES2395268T3 (es)	2013-02-11
ATE265213T1 (de)	2004-05-15
WO1999011250A2 (en)	1999-03-11
US20070185085A1 (en)	2007-08-09
US20120083485A1 (en)	2012-04-05
US20100311724A1 (en)	2010-12-09
US7754710B2 (en)	2010-07-13
CA2302754C (en)	2011-11-08
DE69823520D1 (de)	2004-06-03
EP1327447A1 (de)	2003-07-16
IL134796A0 (en)	2001-04-30
EP1009407A2 (de)	2000-06-21
EP1327447B1 (de)	2011-05-25
AU9217498A (en)	1999-03-22
US20100311725A1 (en)	2010-12-09
ES2224430T3 (es)	2005-03-01
EP1009407B1 (de)	2004-04-28

Publication	Publication Date	Title
ATE510542T1 (de)	2011-06-15	Noribogain zur behandlung von schmerzen und drogenabhängigkeit
ATE399553T1 (de)	2008-07-15	Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE60239612D1 (de)	2011-05-12	Monodisperse mischungen und verfahren zur behandlung von diabetes
DE60031396D1 (de)	2006-11-30	Zubereitung zur behandlung von einer neurologischen erkrankung
EA200000994A1 (ru)	2001-02-26	Применение кабэрголина при лечении синдрома усталых ног
CY1107262T1 (el)	2012-11-21	Θεραπεια της εξαρτησης στερησης
ATE154758T1 (de)	1997-07-15	Levobupivacain nützlich zur behandlung von chronischen schmerzen
ATE144420T1 (de)	1996-11-15	Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE394097T1 (de)	2008-05-15	Verfahren zur verabreichung von buprenorphin zur behandlung von depression
ATE214272T1 (de)	2002-03-15	Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
ATE453402T1 (de)	2010-01-15	Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
DE60229240D1 (de)	2008-11-20	Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
DE69924483D1 (de)	2005-05-04	Kombinationstherapie zur behandlung von tumoren
ATE382354T1 (de)	2008-01-15	Präoperative behandlung von postoperativen schmerzen
ATE262362T1 (de)	2004-04-15	Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
DE69733321D1 (de)	2005-06-23	Olanzapine zur behandlung von drogenmissbrauch
Grabow	1994	Controlled study of the analgetic effectivity of acupuncture
DE69635282D1 (de)	2006-02-23	Behandlung der exzessiven aggressivität mit olanzapine
UA12890A (uk)	1997-02-28	Спосіб акупуhктури
EA199800820A1 (ru)	1999-02-25	Способ лечения злоупотребления лекарственными средствами